|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01276 HENGRUI PHARMA
Nominal 
75.600 -4.150 (-5.204%) Ranking Overview
Ranking based on 7 research report(s)
Average Ranking 2.29
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
2
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 100.00 RMB (cts) | |
| Net Profit | 6,336.53 RMB (MIL) | DPS | -- RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 8,790.00 | 135.00 | 28.00 | -- | 10,181.00 | 7,339.00 |
| 2026 | 10,150.00 | 156.00 | 31.20 | -- | 11,071.00 | 8,584.00 |
| 2027 | 11,924.00 | 181.00 | 34.60 | -- | 13,140.00 | 9,955.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 8,887.00 | 134.00 | -- | CITIC SEC | Buy | 111.00 | 28/08/2025 | |
| 2025 | 10,181.00 | 156.00 | 46.00 | UBS | Buy | 97.80 | 01/09/2025 | |
| 2025 | 7,339.00 | 110.00 | 28.67 | MACQUARIE | OutPerform | 92.00 | 20/08/2025 | |
| 2025 | 8,924.00 | 139.60 | 28.00 | DAIWA | Hold | 86.00 | 13/10/2025 | |
| 2025 | 8,521.10 | 128.00 | 14.82 | MORGAN STANLEY | Overweight | 86.00 | 05/09/2025 | |
| 2025 | 8,790.00 | 138.00 | -- | NOMURA | Buy | 80.57 | 28/07/2025 | |
| 2025 | 8,615.00 | 135.00 | -- | JP MORGAN | Neutral | 78.00 | 23/09/2025 | |
| 2026 | 10,933.00 | 165.00 | -- | CITIC SEC | -- | -- | 28/08/2025 | |
| 2026 | 11,071.00 | 167.00 | 50.00 | UBS | -- | -- | 01/09/2025 | |
| 2026 | 8,584.00 | 130.00 | 35.84 | MACQUARIE | -- | -- | 20/08/2025 | |
| 2026 | 10,340.70 | 156.00 | 14.82 | MORGAN STANLEY | -- | -- | 05/09/2025 | |
| 2026 | 10,001.00 | 150.70 | 31.20 | DAIWA | -- | -- | 13/10/2025 | |
| 2026 | 10,150.00 | 159.00 | -- | NOMURA | -- | -- | 28/07/2025 | |
| 2026 | 9,317.00 | 146.00 | -- | JP MORGAN | -- | -- | 23/09/2025 | |
| 2027 | 13,140.00 | 198.00 | -- | CITIC SEC | -- | -- | 28/08/2025 | |
| 2027 | 12,971.00 | 195.00 | 59.00 | UBS | -- | -- | 01/09/2025 | |
| 2027 | 9,955.00 | 150.00 | 43.01 | MACQUARIE | -- | -- | 20/08/2025 | |
| 2027 | 12,036.30 | 181.00 | 14.82 | MORGAN STANLEY | -- | -- | 05/09/2025 | |
| 2027 | 11,064.00 | 166.70 | 34.60 | DAIWA | -- | -- | 13/10/2025 | |
| 2027 | 11,924.00 | 187.00 | -- | NOMURA | -- | -- | 28/07/2025 | |
| 2027 | 11,196.00 | 176.00 | -- | JP MORGAN | -- | -- | 23/09/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 28/10/2025 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |